share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Mar 22 19:03
Summary by Moomoo AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of Moderna common stock on March 20, 2024. The transaction involved the disposal of 15,000 shares at prices ranging from $101.048 to $103.1753, resulting in a total market value of $1,535,820.07. Following the sale, Afeyan directly holds 2,116,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. total 9,666,038 shares. The sale was executed in the open market.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of Moderna common stock on March 20, 2024. The transaction involved the disposal of 15,000 shares at prices ranging from $101.048 to $103.1753, resulting in a total market value of $1,535,820.07. Following the sale, Afeyan directly holds 2,116,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. total 9,666,038 shares. The sale was executed in the open market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more